Finance

Lists
HR:NYSE
Healthcare Realty Trust Inc
$18.91
-0.79%
(-0.15) 1D
$18.91
0.00% (0.00)
After hours
Closed: Sep 9, 4:00:09 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HR...
Open
$19.02
High
$19.08
Low
$18.73
Mkt. cap
6.48B
Avg. vol.
3.53M
Volume
0.00
Dividend
5.08%
Quarterly dividend
$0.24
Ex-dividend date
Aug 11, 2026
52-wk high
$22.04
52-wk low
$16.31
EPS
-$0.26
Beta
1.21
Shares outstanding
342.72M
No. of employees
539
Open
$19.02
High
$19.08
Low
$18.73
Mkt. cap
6.48B
Avg. vol.
3.53M
Volume
0.00
Dividend
5.08%
Quarterly dividend
$0.24
Ex-dividend date
Aug 11, 2026
52-wk high
$22.04
52-wk low
$16.31
EPS
-$0.26
Beta
1.21
Shares outstanding
342.72M
No. of employees
539
News stories
From web sources and news partners
About Healthcare Realty Trust Inc
CEO-
Employees539
Founded1992
HeadquartersNashville, Tennessee, United States
SectorReal estate investment trust
Websitehealthcarerealty.com
Analyst ratings
Based on 9 analysts giving stock ratings to HR in the past 3 months
Buy
Buy
4
Hold
5
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HR in the last 3 months.
Highest
Current $18.91
$24.00 (+26.92%)
Average
$21.11 (+11.63%)
Lowest
$14.00 (-25.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Kilichowski
Wells Fargo
Hold
Reiterated
$20.00
+5.8%
09/01/2026
Michael Goldsmith
UBS
Hold
Reiterated
$21.00
+11.1%
08/21/2026
Paul Choi
Goldman Sachs
Hold
Maintained
$14.00
-26%
08/16/2026
Michael Carroll
RBC Capital
Hold
Maintained
$22.00
+16.3%
08/07/2026
Nicholas Yulico
Scotiabank
Buy
Maintained
$22.00
+16.3%
07/31/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$24.00
+26.9%
07/31/2026
Michael Gorman
BTIG
Buy
Maintained
$22.00
+16.3%
07/22/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$23.00
+21.6%
07/15/2026
Michael Mueller
J.P. Morgan
Hold
Maintained
$21.00
+11.1%
07/09/2026
Unknown Analyst
Raymond James
Buy
Initiated
$24.00
+26.9%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
$24.00
+26.9%
06/16/2026
Nicholas Joseph
Citi
Hold
Maintained
$21.00
+11.1%
05/07/2026
Juan C. Sanabria
BMO Capital
Hold
Maintained
$20.00
+5.8%
04/30/2026
Last report
Jul 31, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.13 / -$0.04
-264.35%miss
Revenue / Est. (USD)
278.58M / 277.72M
+0.31%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
298.05M
285.67M
279.49M
284.78M
Cost of goods sold
113.58M
111.03M
101.00M
100.45M
Cost of revenue
113.58M
111.03M
101.00M
100.45M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.77M
13.79M
17.34M
14.36M
Operating expense
159.61M
141.20M
146.33M
142.43M
Total operating expenses
273.19M
252.23M
247.32M
242.88M
Operating income
24.86M
33.44M
32.16M
41.90M
Other non operating income
-97.00K
1.11M
-
-
EBT including unusual items
-58.54M
14.59M
21.00K
-43.96M
EBT excluding unusual items
-30.67M
-15.15M
-11.72M
-3.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-57.74M
14.39M
-56.00K
-43.51M
Net profit margin
-19.37%
5.04%
-0.02%
-15.28%
Earnings per share
-0.06
-0.03
-
-
Interest and investment income
-
-
8.00K
19.00K
Interest expense
-55.43M
-49.70M
-43.89M
-45.15M
Net interest expenses
-55.43M
-49.70M
-43.88M
-45.13M
Depreciation and amortization charges
137.84M
127.41M
128.98M
128.06M
EBITDA
174.29M
172.56M
172.95M
181.54M
Gain or loss from assets sale
-76.77M
-135.71M
-10.78M
-3.71M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps